Expression of JAK3, STAT2, STAT4, and STAT6 in pemphigus vulgaris
Open Access
- 1 April 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Immunologic Research
- Vol. 68 (2), 97-103
- https://doi.org/10.1007/s12026-020-09122-y
Abstract
No abstract availableFunding Information
- Uniwersytet Medyczny w Lodzi (503/1-152-01/503-11-002.)
This publication has 33 references indexed in Scilit:
- The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitisJAK-STAT, 2013
- Signaling Dependent and Independent Mechanisms in Pemphigus Vulgaris Blister FormationPLOS ONE, 2012
- JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated DiseaseImmunity, 2012
- Potential role of interleukin-17 in the pathogenesis of bullous pemphigoidMedical Hypotheses, 2010
- Lesional Th17 cells in pemphigus vulgaris and pemphigus foliaceusJournal of Dermatological Science, 2009
- Selectivity and therapeutic inhibition of kinases: to be or not to be?Nature Immunology, 2009
- Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancerBritish Journal of Cancer, 2007
- Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin SyndromeThe New England Journal of Medicine, 2006
- Observer variation in immunohistochemical analysis of protein expression, time for a change?Histopathology, 2006
- The JAK/STAT signaling pathwayJournal of Cell Science, 2004